Liver-directed AAV-HITI efficacy was first assessed in a mouse model of MPS VI,45 a lysosomal storage disorder due to arylsulfatase B (ARSB) deficiency. This evidence concerns the gene ARSB and mucopolysaccharidosis type 6.